Additionally, non-squamous and non-adeno NSCLCs are associated with a poorer prognosis than adenocarcinoma, suggesting that TTF-1 negative NSCLC has a biologically inferior prognosis compared to TTF-1 positive NSCLC (14). This evidence concerns the gene TTF1 and adenocarcinoma.